Dr. Einsley-Marie Janowski, MD, PhD

Dr. Janowski practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Janowski's NPI, 1467744672, was assigned on May 5, 2011. Dr. Janowski graduated from Georgetown University School Of Medicine in 2011. Dr. Janowski holds Virginia license 0101260645.

Dr. Janowski's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

Dr. Janowski's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Janowski is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Janowski to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Janowski's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Janowski practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Janowski's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Janowski is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Janowski's licenses on file in 2 states: Virginia and District of Columbia.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Janowski treats.

CMS data shows 2,909 Medicare services from Dr. Janowski across 20 procedure codes in 2024, for 467 Medicare patients. Medicare paid $184,397 for them.

CMS counts 467 Medicare patients who saw Dr. Janowski in 2024. The largest group is 65 to 74, with 230 patients. 72% of them have cancer, and 69% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Janowski's median patient age at 65, with 62% women.

In 2024, Dr. Janowski wrote 115 Medicare Part D claims for 66 patients. 90% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $844 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Janowski for performance year 2024, reported as part of a group. Dr. Janowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Janowski as offering telehealth.

Dmand AI links 14 papers to Dr. Janowski, published from 2015 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Brachytherapy and Mastectomy, Segmental. Dr. Janowski has published most often in Brachytherapy. Dr. Janowski's most frequent co-authors are Daniel Trifiletti, MD, Clayton Elliott Alonso, MD and Mark Waddle, MD.

CMS Open Payments shows 2 general payments to Dr. Janowski from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Tempus AI, Inc paid the most, $146.

Dmand AI lists 1 award for Dr. Janowski, most recently AOA Inductee 2011 in 2011.

Dr. Janowski graduated from Georgetown University School Of Medicine in 2011. Dr. Janowski is a member of AOA.

Dr. Janowski is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.